The French National Mesothelioma Surveillance Program

Occupational and Environmental Medicine

Volumn 63, Issue 6, 2006, Pages 390-395

  Goldberg, M ^a   Imbernon, E ^a   Rolland, P ^a   Gilg Soit Ilg, A ^a   Saves M ^b   De Quillacq, A ^c   Frenay, C ^d   Chamming's, S ^e   Arveux, P ^f   Boutin, C ^d   Launoy, G ^f   Pairon, J C ^e   Astoul, P ^d   Galateau Salle F ^c   Brochard, P ^b  

^a INSTITUT DE VEILLE SANITAIRE   (France)

^b Laboratoire de Sante Publique   (France)

^c INSERM   (France)

^d HÔPITAL SAINTE MARGUERITE   (France)

^e Inst Inter Univ Medecine Travail   (France)

^f Réseau des Registres du Cancer FRANCIM ^*

Author keywords

[No Author keywords available]

Indexed keywords

ASBESTOS;

ADULT; AGED; ARTICLE; BUILDING INDUSTRY; CASE CONTROL STUDY; CLINICAL ARTICLE; COMPARATIVE STUDY; COMPENSATION; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; LIFESPAN; MALE; MEDICAL RESEARCH; OCCUPATIONAL DISEASE; OCCUPATIONAL EXPOSURE; PLEURA MESOTHELIOMA; PLEURA TUMOR; PRIORITY JOURNAL; RISK FACTOR;

AGED; CASE-CONTROL STUDIES; DISABILITY EVALUATION; FEMALE; FRANCE; HUMANS; INCIDENCE; MALE; MESOTHELIOMA; ODDS RATIO; PLEURAL NEOPLASMS; RISK FACTORS; WORKERS' COMPENSATION;

EID: 33744810322     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.2005.023200     Document Type: Article

References (24)

1. McDonald JC. Epidemiology of pleural cancer. In: Hirsch A, Goldberg M, Martin JP, Masse R, eds. Prevention of respiratory diseases (Lung biology in health and disease). New York: Marcel Dekker, 1993:05-79.
2. INSERM. Effets sur la santé des principaux types d'exposition à l'amiante, Éditions INSERM, Expertises Collectives, Paris, 1997.
3. Gardner MJ, Saracci R. Effects on health of non-occupational exposure to airborne mineral fibers. In: Bignon J, Peto J, Saracci R, eds. Non-occupational exposure to mineral fibers. Lyon: IARC Scientific Publications, 1989:375-97.
4. De Vita V, Hellman S, Rosenberg S. Cancer: principles in practice of oncology, 5th edn. Philadelphia, PA: IARC.
5. McDonald AD, McDonald JC. Malignant mesothelioma in North America. Cancer 1980;4:1650-6.
6. Peto J, Hodgson JT, Matthews FE, et al. Continuing increase in mesothelioma mortality in Britain. Lancet 1995;345:535-9.
7. Iwatsubo Y, Pairon JC, Boutin C, et al. Pleural mesothelioma: dose-response relationship at low level of asbestos exposure in a population-based case-control study. Am J Epidemiol 1998;148:133-42.
8. Merler E, Buiatti E, Vaino H. Surveillance and intervention studies on respiratory cancers in asbestos-exposed workers. Scand J Work Environ Health 997;23:83-92.
9. Price B, Ware A. Mesothelioma trends in the United-States: an update based on Surveillance, Epidemiology, and End Results program data for 1973 through 2003. Am J Epidemiol 2004;159:107-12.
10. Montanaro F, Bray F, Gennaro V, et al. Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends. Cancer Causes Control 2003;14:791-803.
11. Ulvestad B, Kjaerheim K, Moller B, et al. Incidence trends of mesothelioma in Norway, 1965-1999. Int J Cancer 2003;107:94-8.
12. Gilg Soil Ilg A, Bignon J, Valleron AJ. Estimation of the past and future burden of mortality from mesothelioma in France. Occup Environ Med 1998;55:760-5.
13. Banaei A, Auvert B, Goldberg M, et al. Future trends in mortality French men from mesothelioma. Occup Environ Med 2000;57:488-94.
14. Goldberg M, Goldberg S, Luce D. Disparités régionales de la reconnaissance du mésothéliome de la plèvre comme maladie professionnelle en France (1986-1993). Rev Epidemiol Santé Publ 1999;47:421-31.
15. Insee. www.recensement.insee.fr/RP99/.
16. Remonter L, Esteve J, Bouvier Am, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publ 2003;51:3-30.
17. PNSM. Estimation de l'incidence nationale du mésothéliome pleural à partir du Programme national de surveillance du mésothéliome, 1998-1999. Bulletin Épidémiologique Hebdomadaire 2003;40:185-7.
18. Rolland P, Henocque C, Gilg Soit Ilg A, et al. Occupations and industries at high risk for pleural mesothelioma: a French population-based case-control study (1998-2002). Occup Environ Med 2004;61:e42.
19. Galateau-Salle-F, Abdalsamad I, Brambilla E, et al. Immunohistochemical diagnosis of mesothelioma: experience of the French mesothelioma panel [Mesopath Group). Mod Pathol 2000;13:209A.
20. Galateau-Sallé F, Vignaud JM, Burke L, et al. Well differentiated papillary mesothelioma of the pleura: a series of 24 cases. Am J Surg Pathol 2004;28:534-40.
21. Chomming's S, Bertin N, Rolland P, et al. Évaluation de la prise en charge médico-sociale des mésothéliomes pleuraux. Années 1999-2001. Bulletin Épidémiologique Hebdomadaire 2003;40:187-8.
22. Leigh J, Davison P, Hendrie L, et al. Malignant mesothelioma in Australia, 1945-2000. Am J Ind Med 2000;41:188-201.
23. Nesti M, Marinaccio A, Chellini E, et al. Malignant mesothelioma in Italy, 1997. Am J Ind Med 2004;45:55-62.
24. EUROGIP. État des lieux sur les cancers professionnels en Europe, Rapport Eurogip-02/F. Paris, December, 2002.